Mounjaro is a once weekly injectable medicine approved for adults with type 2 diabetes to be used along with diet and exercise to improve blood sugar…
Time in Range Outcomes from Six European Countries
Our European research…
Eight dQ&A® Abstracts Presented at ATTD 2023
We are excited to announce that…
dQ&A® Data on Advances in Disease-Modifying Interventions Presented at Global Congress on Cardiology
This research had four…
Research by Trevor Bell Published in Current Diabetes Reports
Psychosocial Assessment Tools for Youth…
Abstract Published at European Association for the Study of Diabetes (EASD) Annual Meeting
dQ&A is excited to share…
Drastic Differences in Perceived Benefits Among Digital Health Products for People with Diabetes
A semi-annual national…
T2 Insulin Insights Data Service
T2 Insulin Insights is a unique semi-annual Research Service…
Donating to Spare a Rose for Ukraine
In our most recent survey, we gave our community…
Major Grocery Chains Failing to Meet the Needs of People With Diabetes
A large, nationally…
